Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients
The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors ha...
Saved in:
Published in | PloS one Vol. 10; no. 7; p. e0133589 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
24.07.2015
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection.
Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed.
CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test).
This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not. |
---|---|
AbstractList | The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection.
Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed.
CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test).
This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not. The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection. Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed. CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/[mu]L (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test). This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not. Background The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection. Methods Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed. Results CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/[mu]L (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test). Conclusions This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not. Background The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today’s rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection. Methods Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed. Results CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test). Conclusions This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not. The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection.Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed.CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test).This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not. The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection.BACKGROUNDThe prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection.Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed.METHODSTrends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed.CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test).RESULTSCE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test).This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not.CONCLUSIONSThis large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not. Background The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today’s rapidly aging society among non-HIV-infected patients. However, few studies have investigated long-term CE trends, and CE risk factors have not been studied in a large sample, case-control study. This study aimed to determine long-term trends in CE prevalence and associated risk factors for patients with or without HIV infection. Methods Trends in CE prevalence were explored in a cohort of 80,219 patients who underwent endoscopy between 2002 and 2014. Risks for CE were examined among a subcohort of 6,011 patients. In risk analysis, we assessed lifestyles, infections, co-morbidities, immunosuppressants, and proton-pump inhibitors (PPIs). All patients were tested for HIV, hepatitis B or C virus, and syphilis infection. For HIV-infected patients, sexual behavior, CD4 cell count, history of HAART were also assessed. Results CE prevalence was 1.7% (1,375/80,219) in all patients, 9.8% (156/1,595) in HIV-infected patients, and 1.6% (1,219/78,624) in non-HIV-infected patients. CE prevalence from 2002-2003 to 2012-2014 tended to increase in non-HIV-infected patients (0.6% to 2.5%; P<0.01) and decrease in HIV-infected patients (13.6% to 9.0%; P=0.097). Multivariate analysis revealed increasing age (odds ratio [OR], 1.02; p=0.007), HIV infection (OR, 4.92; p<0.001), and corticosteroid use (OR, 5.90; p<0.001) were significantly associated with CE, and smoking (OR, 1.32; p=0.085) and acetaminophen use (OR, 1.70; p=0.097) were marginally associated. No significant association was found with alcohol consumption, hepatitis B or C virus, syphilis, diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic kidney disease, liver cirrhosis, anticancer, or PPIs use. In HIV-infected patients, CD4 cell count <100/μL (OR, 4.83; p<0.001) and prior HAART (OR, 0.35; p=0.006) were independently associated with CE, but sexual behavior was not. Among corticosteroid users, CE was significantly associated with higher prednisone-equivalent dose (p=0.043 for trend test). Conclusions This large, endoscopy-based study demonstrated that CE prevalence increased in non-HIV-infected patients but decreased in HIV-infected patients over 13 years. Risk analysis revealed that increasing age, HIV infection, and corticosteroids use, particularly at higher doses, were independently associated with CE, but alcohol, other infections, diabetes, anticancer drugs, and PPIs use were not. |
Audience | Academic |
Author | Mimori, Akio Sekine, Katsunori Kobayakawa, Masao Mine, Sohtaro Uemura, Naomi Kikuchi, Yoshimi Watanabe, Koji Yokoi, Chizu Igari, Toru Shimbo, Takuro Yazaki, Hirohisa Akiyama, Junichi Takahashi, Yuko Okubo, Hidetaka Gatanaga, Hiroyuki Nishijima, Takeshi Aoki, Tomonori Takahashi, Yuta Oka, Shinichi Nagata, Naoyoshi Sakurai, Toshiyuki Watanabe, Kazuhiro Teruya, Katsuji |
AuthorAffiliation | 6 Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Kohnodai Hospital, Chiba, Japan University of Wisconsin Medical School, UNITED STATES 2 Ohta Nishinouchi Hospital, Fukushima, Japan 5 Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan 3 Division of AIDS Clinical Center (ACC), National Center for Global Health and Medicine, Tokyo, Japan 4 Department of Pathology, National Center for Global Health and Medicine, Tokyo, Japan 1 Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan |
AuthorAffiliation_xml | – name: University of Wisconsin Medical School, UNITED STATES – name: 6 Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Kohnodai Hospital, Chiba, Japan – name: 5 Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan – name: 4 Department of Pathology, National Center for Global Health and Medicine, Tokyo, Japan – name: 3 Division of AIDS Clinical Center (ACC), National Center for Global Health and Medicine, Tokyo, Japan – name: 1 Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan – name: 2 Ohta Nishinouchi Hospital, Fukushima, Japan |
Author_xml | – sequence: 1 givenname: Yuta surname: Takahashi fullname: Takahashi, Yuta – sequence: 2 givenname: Naoyoshi surname: Nagata fullname: Nagata, Naoyoshi – sequence: 3 givenname: Takuro surname: Shimbo fullname: Shimbo, Takuro – sequence: 4 givenname: Takeshi surname: Nishijima fullname: Nishijima, Takeshi – sequence: 5 givenname: Koji surname: Watanabe fullname: Watanabe, Koji – sequence: 6 givenname: Tomonori surname: Aoki fullname: Aoki, Tomonori – sequence: 7 givenname: Katsunori surname: Sekine fullname: Sekine, Katsunori – sequence: 8 givenname: Hidetaka surname: Okubo fullname: Okubo, Hidetaka – sequence: 9 givenname: Kazuhiro surname: Watanabe fullname: Watanabe, Kazuhiro – sequence: 10 givenname: Toshiyuki surname: Sakurai fullname: Sakurai, Toshiyuki – sequence: 11 givenname: Chizu surname: Yokoi fullname: Yokoi, Chizu – sequence: 12 givenname: Masao surname: Kobayakawa fullname: Kobayakawa, Masao – sequence: 13 givenname: Hirohisa surname: Yazaki fullname: Yazaki, Hirohisa – sequence: 14 givenname: Katsuji surname: Teruya fullname: Teruya, Katsuji – sequence: 15 givenname: Hiroyuki surname: Gatanaga fullname: Gatanaga, Hiroyuki – sequence: 16 givenname: Yoshimi surname: Kikuchi fullname: Kikuchi, Yoshimi – sequence: 17 givenname: Sohtaro surname: Mine fullname: Mine, Sohtaro – sequence: 18 givenname: Toru surname: Igari fullname: Igari, Toru – sequence: 19 givenname: Yuko surname: Takahashi fullname: Takahashi, Yuko – sequence: 20 givenname: Akio surname: Mimori fullname: Mimori, Akio – sequence: 21 givenname: Shinichi surname: Oka fullname: Oka, Shinichi – sequence: 22 givenname: Junichi surname: Akiyama fullname: Akiyama, Junichi – sequence: 23 givenname: Naomi surname: Uemura fullname: Uemura, Naomi |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26208220$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk11rFDEUhgep2A_9B6IBQRTcNR-zs0kvhFJau7DQ0tbehmxysps6m6xJptr_4w81u91KtxSRuchw5nnf5LyTs1tt-eChql4T3CdsSD5fhy561fYXpdzHhLEBF8-qHSIY7TUUs60H79vVbkrXGA8Yb5oX1TYtRU4p3ql-j4Of9i4hztFlBG8Sch4dpbCYqSmoFh0qb5xxKrmEziLcqBa8BlSq6CCloJ3KYNC5S9_RsdI5xIR-ujxDIa7W0GV0MrpCI29BZxf8PhpD0fmEbAzz4oOOvAlJh4XT6CJ35hYFizj-RIlAZyo78Dm9rJ5b1SZ4tV73qm_HR5eHJ73x6dfR4cG4pxtBc6_mQ2UshXqCKRbaKKUxt9hw0TClieaUaKuMZpSzARHNBGAiWANCUwVDy9le9fbOd9GGJNcBJ0kawRtCasEKMbojTFDXchHdXMVbGZSTq0KIU6lidroFWbIvCVuGB1jXxtYCWFNzRcUQOFXCFq8v6926yRyMLp1G1W6Ybn7xbian4UbWA1JzgovBh7VBDD86SFnOXdLQtspD6FbnFuXQhNUFffcIfbq7NTUtv1k6b0PZVy9N5UFNqRCCk2Gh-k9Q5TEwd7rcRutKfUPwcUNQmAy_8lR1KcnRxfn_s6dXm-z7B-ysXNc8S6HtlvcsbYJvHib9N-L7MSjA_h2gY0gpgpXaZbX0Ka25VhIslzN3H5pczpxcz1wR14_E9_7_lP0BOS8wuw |
CitedBy_id | crossref_primary_10_1016_j_med_2024_01_002 crossref_primary_10_1155_2019_3585136 crossref_primary_10_1002_jcla_23826 crossref_primary_10_1177_2050640616684404 crossref_primary_10_1556_650_2023_32768 crossref_primary_10_12998_wjcc_v10_i30_10896 crossref_primary_10_1093_dote_doy094 crossref_primary_10_1097_MPG_0000000000003927 crossref_primary_10_1016_j_med_2024_01_009 crossref_primary_10_36106_gjra_6409753 crossref_primary_10_1007_s11938_023_00435_z crossref_primary_10_25208_0042_4609_2017_93_3_21_31 crossref_primary_10_3389_fmicb_2022_983348 crossref_primary_10_1111_myc_13585 crossref_primary_10_1097_MPG_0000000000003523 crossref_primary_10_22416_1382_4376_2020_30_5_63_83 crossref_primary_10_1007_s40267_017_0473_z crossref_primary_10_1136_jcp_2024_209908 crossref_primary_10_3390_ijms20236031 crossref_primary_10_1007_s00405_020_05865_4 crossref_primary_10_1016_j_jinf_2024_106172 crossref_primary_10_17941_agd_978470 crossref_primary_10_5812_archcid_114631 crossref_primary_10_1007_s40261_017_0519_y crossref_primary_10_1155_2021_8869494 crossref_primary_10_3390_jcm8010076 crossref_primary_10_1371_journal_pone_0183951 crossref_primary_10_1055_s_0040_1714073 crossref_primary_10_1186_s13104_021_05498_8 crossref_primary_10_4253_wjge_v15_i6_480 crossref_primary_10_1111_myc_13753 crossref_primary_10_1093_ofid_ofae117 crossref_primary_10_17940_endoskopi_570941 crossref_primary_10_1007_s11695_021_05398_7 crossref_primary_10_2478_prolas_2024_0044 crossref_primary_10_1093_ajcp_aqw210 crossref_primary_10_7759_cureus_24312 crossref_primary_10_1186_s12879_023_08455_x crossref_primary_10_1038_s41598_021_00132_w crossref_primary_10_1111_hiv_12806 crossref_primary_10_14423_SMJ_0000000000001591 crossref_primary_10_1016_j_cgh_2018_04_035 crossref_primary_10_1155_2019_8243868 crossref_primary_10_1111_his_14063 |
Cites_doi | 10.1093/clinids/9.1.88 10.1007/s100960050437 10.1016/0016-5085(94)90613-0 10.1056/NEJMoa001999 10.3748/wjg.v9.i10.2328 10.1007/BF02779203 10.1111/j.1442-2050.2006.00563.x 10.1592/phco.27.11.1512 10.1002/path.2104 10.1111/j.1572-0241.2000.01768.x 10.3201/eid1805.111275 10.2165/00003495-200363100-00004 10.3349/ymj.2013.54.1.160 10.1586/14787210.2.4.521 10.1016/S0016-5085(76)80347-2 10.1097/QAI.0000000000000016 10.4065/71.1.5 10.1016/S0140-6736(11)61176-8 10.1016/S0140-6736(03)14904-5 10.1046/j.1442-2050.2003.00305.x 10.1086/596757 10.1111/j.1572-0241.2005.41949.x 10.1111/j.1440-1746.2009.06188.x 10.1111/dote.12102 10.1001/archinte.1991.00400080067012 10.7326/0003-4819-78-2-271 10.1055/s-2007-1005716 10.1038/nature06516 10.1371/journal.pone.0058217 10.1128/IAI.58.1.107-113.1990 10.1006/cimm.1994.1230 10.1111/j.1468-1293.2009.00807.x |
ContentType | Journal Article |
Copyright | COPYRIGHT 2015 Public Library of Science 2015 Takahashi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2015 Takahashi et al 2015 Takahashi et al |
Copyright_xml | – notice: COPYRIGHT 2015 Public Library of Science – notice: 2015 Takahashi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2015 Takahashi et al 2015 Takahashi et al |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PTHSS PYCSY RC3 7X8 5PM DOA |
DOI | 10.1371/journal.pone.0133589 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni Edition) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agricultural Science Database Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Agricultural Science Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) Medicine |
DocumentTitleAlternate | CE Trends and Risks |
EISSN | 1932-6203 |
ExternalDocumentID | 1698611493 oai_doaj_org_article_932220f3050c4df49e3648a297e82a9f PMC4514810 3755846851 A422999817 26208220 10_1371_journal_pone_0133589 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM CGR CUY CVF ECM EIF IPNFZ NPM PJZUB PPXIY PQGLB RIG BBORY PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI RC3 7X8 5PM PUEGO AAPBV ABPTK |
ID | FETCH-LOGICAL-c692t-487adf2e4b0209cdaac08f0d8963ac1c821cfadc32835196beeb936e9c2ae7f83 |
IEDL.DBID | M48 |
ISSN | 1932-6203 |
IngestDate | Sun Sep 03 00:14:33 EDT 2023 Wed Aug 27 01:32:13 EDT 2025 Thu Aug 21 14:37:16 EDT 2025 Fri Jul 11 04:57:18 EDT 2025 Fri Jul 25 11:47:13 EDT 2025 Tue Jun 17 21:10:14 EDT 2025 Tue Jun 10 20:17:45 EDT 2025 Fri Jun 27 04:53:41 EDT 2025 Fri Jun 27 04:07:19 EDT 2025 Thu May 22 20:57:10 EDT 2025 Mon Jul 21 05:59:41 EDT 2025 Thu Apr 24 22:56:36 EDT 2025 Tue Jul 01 01:53:53 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c692t-487adf2e4b0209cdaac08f0d8963ac1c821cfadc32835196beeb936e9c2ae7f83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Conceived and designed the experiments: Yuta Takahashi NN. Performed the experiments: Yuta Takahashi NN. Analyzed the data: Yuta Takahashi NN T Shimbo. Contributed reagents/materials/analysis tools: NN TN KW TA KS HO KW T Sakurai CY MK HY KT HG YK SM TI Yuko Takahashi. Wrote the paper: Yuta Takahashi NN AM SO JA NU. Competing Interests: The authors have declared that no competing interests exist. |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0133589 |
PMID | 26208220 |
PQID | 1698611493 |
PQPubID | 1436336 |
ParticipantIDs | plos_journals_1698611493 doaj_primary_oai_doaj_org_article_932220f3050c4df49e3648a297e82a9f pubmedcentral_primary_oai_pubmedcentral_nih_gov_4514810 proquest_miscellaneous_1699493134 proquest_journals_1698611493 gale_infotracmisc_A422999817 gale_infotracacademiconefile_A422999817 gale_incontextgauss_ISR_A422999817 gale_incontextgauss_IOV_A422999817 gale_healthsolutions_A422999817 pubmed_primary_26208220 crossref_citationtrail_10_1371_journal_pone_0133589 crossref_primary_10_1371_journal_pone_0133589 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-07-24 |
PublicationDateYYYYMMDD | 2015-07-24 |
PublicationDate_xml | – month: 07 year: 2015 text: 2015-07-24 day: 24 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PloS one |
PublicationTitleAlternate | PLoS One |
PublicationYear | 2015 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | RA Giannella (ref35) 1973; 78 M Bonacini (ref25) 1991; 151 E Balish (ref33) 1990; 58 M Nkuize (ref24) 2010; 11 JH Choi (ref10) 2013; 54 PH Baehr (ref21) 1994; 106 W Lutz (ref27) 2008; 451 Y Naito (ref23) 1988; 23 N Uemura (ref15) 2001; 345 MS Lionakis (ref29) 2003; 362 KE Monkemuller (ref11) 2000; 95 J Yakoob (ref8) 2003; 9 KM Fock (ref14) 2010; 25 N Nagata (ref13) 2012; 18 A Antinori (ref4) 1995; 27 BE Kodsi (ref22) 1976; 71 Y Hamada (ref20) 2014; 65 A Chocarro Martinez (ref6) 2000; 19 A Mocroft (ref12) 2005; 100 RR Wheeler (ref1) 1987; 9 SH Yale (ref31) 1996; 71 N Tamiya (ref28) 2011; 378 JA Vazquez (ref2) 2003; 63 N Weerasuriya (ref7) 2006; 19 PG Pappas (ref3) 2009; 48 AJ Porges (ref32) 1992; 19 N Nagata (ref16) 2014 JA Underwood (ref5) 2003; 16 P Willemot (ref26) 2004; 2 N Asayama (ref18) 2014; 27 S Heidenreich (ref30) 1994; 157 CK Yeh (ref34) 1988; 1 AL Gruver (ref9) 2007; 211 S Nishimura (ref17) 2013; 8 K Asare (ref19) 2007; 27 964563 - Gastroenterology. 1976 Nov;71(5):715-9 12823199 - Dis Esophagus. 2003;16(2):66-9 18204438 - Nature. 2008 Feb 7;451(7179):716-9 3823720 - Rev Infect Dis. 1987 Jan-Feb;9(1):88-96 14562403 - World J Gastroenterol. 2003 Oct;9(10):2328-31 16722997 - Dis Esophagus. 2006;19(3):189-92 10746494 - Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):96-100 15482218 - Expert Rev Anti Infect Ther. 2004 Aug;2(4):521-32 17200946 - J Pathol. 2007 Jan;211(2):144-56 3181663 - Gastroenterol Jpn. 1988 Aug;23(4):363-70 23826847 - Dis Esophagus. 2014 Apr;27(3):214-9 1404153 - J Rheumatol. 1992 Aug;19(8):1191-4 11556297 - N Engl J Med. 2001 Sep 13;345(11):784-9 8538233 - Mayo Clin Proc. 1996 Jan;71(1):5-13 25339607 - J Gastroenterol Hepatol. 2015 Feb;30(2):292-8 14654323 - Lancet. 2003 Nov 29;362(9398):1828-38 17963461 - Pharmacotherapy. 2007 Nov;27(11):1512-28 4567180 - Ann Intern Med. 1973 Feb;78(2):271-6 8069920 - Cell Immunol. 1994 Sep;157(2):320-7 20146733 - HIV Med. 2010 Jul 1;11(6):412-7 21885099 - Lancet. 2011 Sep 24;378(9797):1183-92 23225813 - Yonsei Med J. 2013 Jan 1;54(1):160-5 22515839 - Emerg Infect Dis. 2012 May;18(5):717-24 3216316 - J Acquir Immune Defic Syndr. 1988;1(4):361-6 2403528 - Infect Immun. 1990 Jan;58(1):107-13 1651690 - Arch Intern Med. 1991 Aug;151(8):1567-72 10685750 - Am J Gastroenterol. 2000 Feb;95(2):457-62 19191635 - Clin Infect Dis. 2009 Mar 1;48(5):503-35 24525468 - J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):312-7 20370726 - J Gastroenterol Hepatol. 2010 Mar;25(3):479-86 7980741 - Gastroenterology. 1994 Feb;106(2):509-32 15984964 - Am J Gastroenterol. 2005 Jul;100(7):1446-54 12699400 - Drugs. 2003;63(10):971-89 23555571 - PLoS One. 2013;8(3):e58217 7588351 - Endoscopy. 1995 Jun;27(5):371-6 |
References_xml | – volume: 9 start-page: 88 year: 1987 ident: ref1 article-title: Esophagitis in the immunocompromised host: Role of esophagoscopy in diagnosis publication-title: Rev Infect Dis doi: 10.1093/clinids/9.1.88 – volume: 19 start-page: 1191 year: 1992 ident: ref32 article-title: Patients with systemic lupus erythematosus at risk for pneumocystis carinii pneumonia publication-title: J Rheumatol – volume: 19 start-page: 96 year: 2000 ident: ref6 article-title: Risk factors for esophageal candidiasis publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s100960050437 – volume: 106 start-page: 509 year: 1994 ident: ref21 article-title: Esophageal infections: Risk factors, presentation, diagnosis, and treatment publication-title: Gastroenterology doi: 10.1016/0016-5085(94)90613-0 – volume: 345 start-page: 784 year: 2001 ident: ref15 article-title: Helicobacter pylori infection and the development of gastric cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa001999 – volume: 9 start-page: 2328 year: 2003 ident: ref8 article-title: Candida esophagitis: Risk factors in non-HIV population in pakistan publication-title: World J Gastroenterol doi: 10.3748/wjg.v9.i10.2328 – volume: 23 start-page: 363 year: 1988 ident: ref23 article-title: Esophageal candidiasis publication-title: Gastroenterol Jpn doi: 10.1007/BF02779203 – volume: 19 start-page: 189 year: 2006 ident: ref7 article-title: A study of candida esophagitis in elderly patients attending a district general hospital in the UK publication-title: Dis Esophagus doi: 10.1111/j.1442-2050.2006.00563.x – volume: 27 start-page: 1512 year: 2007 ident: ref19 article-title: Diagnosis and treatment of adrenal insufficiency in the critically ill patient publication-title: Pharmacotherapy doi: 10.1592/phco.27.11.1512 – volume: 211 start-page: 144 year: 2007 ident: ref9 article-title: Immunosenescence of ageing publication-title: J Pathol doi: 10.1002/path.2104 – volume: 95 start-page: 457 year: 2000 ident: ref11 article-title: Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2000.01768.x – volume: 18 start-page: 717 year: 2012 ident: ref13 article-title: Risk factors for intestinal invasive amebiasis in japan, 2003–2009 publication-title: Emerg Infect Dis doi: 10.3201/eid1805.111275 – volume: 63 start-page: 971 year: 2003 ident: ref2 article-title: Invasive oesophageal candidiasis: Current and developing treatment options publication-title: Drugs doi: 10.2165/00003495-200363100-00004 – volume: 54 start-page: 160 year: 2013 ident: ref10 article-title: Prevalence and risk factors of esophageal candidiasis in healthy individuals: A single center experience in korea publication-title: Yonsei Med J doi: 10.3349/ymj.2013.54.1.160 – volume: 2 start-page: 521 year: 2004 ident: ref26 article-title: Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy publication-title: Expert Rev Anti Infect Ther doi: 10.1586/14787210.2.4.521 – volume: 71 start-page: 715 year: 1976 ident: ref22 article-title: Candida esophagitis: A prospective study of 27 cases publication-title: Gastroenterology doi: 10.1016/S0016-5085(76)80347-2 – volume: 65 start-page: 312 year: 2014 ident: ref20 article-title: Impact of HIV infection on colorectal tumors: A prospective colonoscopic study of asian patients publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000000016 – volume: 71 start-page: 5 year: 1996 ident: ref31 article-title: Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: Associated illness and prior corticosteroid therapy publication-title: Mayo Clin Proc doi: 10.4065/71.1.5 – volume: 378 start-page: 1183 year: 2011 ident: ref28 article-title: Population ageing and wellbeing: Lessons from japan's long-term care insurance policy publication-title: Lancet doi: 10.1016/S0140-6736(11)61176-8 – volume: 362 start-page: 1828 year: 2003 ident: ref29 article-title: Glucocorticoids and invasive fungal infections publication-title: Lancet doi: 10.1016/S0140-6736(03)14904-5 – volume: 16 start-page: 66 year: 2003 ident: ref5 article-title: Clinical findings and risk factors for candida esophagitis in outpatients publication-title: Dis Esophagus doi: 10.1046/j.1442-2050.2003.00305.x – volume: 48 start-page: 503 year: 2009 ident: ref3 article-title: Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of america publication-title: Clin Infect Dis doi: 10.1086/596757 – year: 2014 ident: ref16 article-title: Risk of peptic ulcer bleeding associated with helicobacter pylori infection, NSAIDs, low-dose aspirin, and antihypertensive drugs: A case-control study publication-title: J Gastroenterol Hepatol – volume: 100 start-page: 1446 year: 2005 ident: ref12 article-title: Decline in esophageal candidiasis and use of antimycotics in european patients with HIV publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2005.41949.x – volume: 25 start-page: 479 year: 2010 ident: ref14 article-title: Epidemiology of helicobacter pylori infection and gastric cancer in asia publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2009.06188.x – volume: 27 start-page: 214 year: 2014 ident: ref18 article-title: Relationship between clinical factors and severity of esophageal candidiasis according to kodsi's classification publication-title: Dis Esophagus doi: 10.1111/dote.12102 – volume: 151 start-page: 1567 year: 1991 ident: ref25 article-title: The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients publication-title: Arch Intern Med doi: 10.1001/archinte.1991.00400080067012 – volume: 78 start-page: 271 year: 1973 ident: ref35 article-title: Influence of gastric acidity on bacterial and parasitic enteric infections. A perspective publication-title: Ann Intern Med doi: 10.7326/0003-4819-78-2-271 – volume: 27 start-page: 371 year: 1995 ident: ref4 article-title: Presumptive clinical criteria versus endoscopy in the diagnosis of candida esophagitis at various HIV-1 disease stages publication-title: Endoscopy doi: 10.1055/s-2007-1005716 – volume: 451 start-page: 716 year: 2008 ident: ref27 article-title: The coming acceleration of global population ageing publication-title: Nature doi: 10.1038/nature06516 – volume: 8 start-page: e58217 year: 2013 ident: ref17 article-title: Factors associated with esophageal candidiasis and its endoscopic severity in the era of antiretroviral therapy publication-title: PLoS One doi: 10.1371/journal.pone.0058217 – volume: 58 start-page: 107 year: 1990 ident: ref33 article-title: Correlates of cell-mediated immunity in candida albicans-colonized gnotobiotic mice publication-title: Infect Immun doi: 10.1128/IAI.58.1.107-113.1990 – volume: 157 start-page: 320 year: 1994 ident: ref30 article-title: Glucocorticoid-induced alterations of monocyte defense mechanisms against candida albicans publication-title: Cell Immunol doi: 10.1006/cimm.1994.1230 – volume: 11 start-page: 412 year: 2010 ident: ref24 article-title: Upper gastrointestinal endoscopic findings in the era of highly active antiretroviral therapy publication-title: HIV Med doi: 10.1111/j.1468-1293.2009.00807.x – volume: 1 start-page: 361 year: 1988 ident: ref34 article-title: Oral defense mechanisms are impaired early in HIV-1 infected patients publication-title: J Acquir Immune Defic Syndr – reference: 16722997 - Dis Esophagus. 2006;19(3):189-92 – reference: 15984964 - Am J Gastroenterol. 2005 Jul;100(7):1446-54 – reference: 12699400 - Drugs. 2003;63(10):971-89 – reference: 14562403 - World J Gastroenterol. 2003 Oct;9(10):2328-31 – reference: 3181663 - Gastroenterol Jpn. 1988 Aug;23(4):363-70 – reference: 8069920 - Cell Immunol. 1994 Sep;157(2):320-7 – reference: 17200946 - J Pathol. 2007 Jan;211(2):144-56 – reference: 8538233 - Mayo Clin Proc. 1996 Jan;71(1):5-13 – reference: 25339607 - J Gastroenterol Hepatol. 2015 Feb;30(2):292-8 – reference: 12823199 - Dis Esophagus. 2003;16(2):66-9 – reference: 11556297 - N Engl J Med. 2001 Sep 13;345(11):784-9 – reference: 20370726 - J Gastroenterol Hepatol. 2010 Mar;25(3):479-86 – reference: 18204438 - Nature. 2008 Feb 7;451(7179):716-9 – reference: 23826847 - Dis Esophagus. 2014 Apr;27(3):214-9 – reference: 1404153 - J Rheumatol. 1992 Aug;19(8):1191-4 – reference: 17963461 - Pharmacotherapy. 2007 Nov;27(11):1512-28 – reference: 14654323 - Lancet. 2003 Nov 29;362(9398):1828-38 – reference: 2403528 - Infect Immun. 1990 Jan;58(1):107-13 – reference: 10685750 - Am J Gastroenterol. 2000 Feb;95(2):457-62 – reference: 19191635 - Clin Infect Dis. 2009 Mar 1;48(5):503-35 – reference: 22515839 - Emerg Infect Dis. 2012 May;18(5):717-24 – reference: 10746494 - Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):96-100 – reference: 7588351 - Endoscopy. 1995 Jun;27(5):371-6 – reference: 3216316 - J Acquir Immune Defic Syndr. 1988;1(4):361-6 – reference: 15482218 - Expert Rev Anti Infect Ther. 2004 Aug;2(4):521-32 – reference: 21885099 - Lancet. 2011 Sep 24;378(9797):1183-92 – reference: 23225813 - Yonsei Med J. 2013 Jan 1;54(1):160-5 – reference: 7980741 - Gastroenterology. 1994 Feb;106(2):509-32 – reference: 24525468 - J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):312-7 – reference: 4567180 - Ann Intern Med. 1973 Feb;78(2):271-6 – reference: 964563 - Gastroenterology. 1976 Nov;71(5):715-9 – reference: 23555571 - PLoS One. 2013;8(3):e58217 – reference: 1651690 - Arch Intern Med. 1991 Aug;151(8):1567-72 – reference: 3823720 - Rev Infect Dis. 1987 Jan-Feb;9(1):88-96 – reference: 20146733 - HIV Med. 2010 Jul 1;11(6):412-7 |
SSID | ssj0053866 |
Score | 2.3629549 |
Snippet | The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients or today's... Background The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients... Background The prevalence of candida esophagitis (CE) might be changing in an era of highly active antiretroviral therapy (HAART) among HIV-infected patients... |
SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | e0133589 |
SubjectTerms | Acetaminophen Acquired immune deficiency syndrome Activities of daily living Aged Aged, 80 and over Aging AIDS Alcoholic beverages Antineoplastic drugs Antiretroviral agents Antiretroviral drugs Antitumor agents Cancer therapies Candida Candidiasis Candidiasis - epidemiology Cardiovascular diseases Case-Control Studies CD4 antigen Chronic kidney failure Cirrhosis Coinfection Corticoids Corticosteroids Defense mechanisms Diabetes mellitus Drug therapy Drugs Endoscopy Endoscopy, Digestive System Esophagitis Esophagitis - epidemiology Esophagitis - microbiology Esophagus Female Gastric cancer Gastroenterology Glucocorticoids Health aspects Health risks Hepatitis Hepatitis B Hepatology Highly active antiretroviral therapy HIV HIV infections HIV Infections - epidemiology HIV tests Hospitals Human immunodeficiency virus Humans Immunosuppressive agents Infections Kidney transplantation Liver Liver cirrhosis Liver diseases Male Medical diagnosis Medical research Medical screening Medicine Middle Aged Multivariate analysis Mycoses Odds Ratio Patients Pneumonia Population Prednisone Prevalence Prevalence studies (Epidemiology) Proton pump inhibitors Rheumatic diseases Risk analysis Risk factors Sexual behavior Sexually transmitted diseases Smoking STD Stomach cancer Studies Syphilis Trends Viruses |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnrggyquhBQxCAiTSJrHXibmValddVB4qbdVb5PhRVlTJqtk98H_4oczE3miDKpUDp5XiibXxzHweJzPfEPJ6bFItc1fE3GoWc-GSuOIOHC9hPFfYHqmr8P78RRyd8U8X44uNVl-YE-bpgf3C7Uv8FJA4MMtEc-O4tEzwAmbJbZEp6RB9Yc9bH6Y8BoMXCxEK5Vie7ge97C2a2u5B0MPG2NZ9YyPq-Pp7VB4trpr2ppDz78zJja1oep_cCzEkPfD_fYvcsfUDshW8tKVvA5X0u4fk93FTX8angL7UJ7_SeU0n2LkAYASmOMSiFrCQdt5SJHNSXQkShat0rTdr6Mm8_UmnvjEPxRe3tLnufpvVkh7NzuksZHTVH-gxICcYMsWyFZiHTmrTYOXLXFNMWfxFG0eL5D0gGP3mKV3bR-RsOjk9PIpDX4ZYC5ktYzjjKOMyyyuINaU2SumkcIkpwJmVTnWRpdopoxlyuYGHV9ZWkgkrdaYs2AV7TEY1aGKb0MxVAMcVT6w0nKsU9To2lWAiVyyrTETYWkmlDqTl2Dvjquy-xOVwePFrXqJqy6DaiMT9XQtP2nGL_EfUfy-LlNvdBTDEMhhieZshRuQFWk_p61d74CgPeAZbvizSPCKvOgmk3agxr-dSrdq2nH09_weh7ycDoTdByDWwHFqFWgp4JqTzGkjuDiQBPPRgeBttfb0qbZkKWQg4I0sGd67t_-bhl_0wToq5erVtVp2MBIGU8Yg88e7Sryy2P4CQNIlIPnCkwdIPR-r5j471nENoX6TJ0_-hqx1yFwLfMb6jz_guGS2vV_YZBJfL6nmHI38AM7l3vg priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegSIgXxMbHAgMMQgIksiWxm8S8oDG1atEGaGxT3yLHHyViSkrTPvD_8Idyl7hhQRPwVCm-RKnv7pezffc7Ql4MdahEYlOfG8V8HtvAz7kFxwsYTyS2R2oqvI8_xpMz_mE2nLkNt9qlVW4wsQFqXSncI98PY5HGELwL9m7x3ceuUXi66lpoXCc3kLoMU7qSWbfgAl-OY1cux5Jw32lnb1GVZg9CHzbE5u6XPkcNa3-HzYPFRVVfFXj-mT956YM0vkNuu0iSHrSq3yLXTLlNbh67s_JtsuXctqavHLf067vk51FVzv1TgGPaZsPSoqQjbGUAuAJPO8QqFzCZuqgpsjvJpiaJwlW6UaTR9KSov9Fx26mH4k4urZbNb7Ve0cn0nE5dilf5lh4BlIJlU6xjgefQUakrLIUpFMUcxh-0sjQN3gCk0c8tx2t9j5yNR6eHE981avBVLKKVD4seqW1keA7Bp1BaShWkNtApeLdUoUqjUFmpFUNyN3D53JhcsNgIFUkDhsLuk0EJStkhNLI54HPOAyM05zKUWPmr85jFiWRRrj3CNvrKlGMxx2YaF1lzNJfAaqad_gy1nDkte8Tv7lq0LB7_kH-PptDJIgd3c6FazjPn0pnAQ6rAAmAGimvLhWExT_GFTRpJYT3yFA0pawtaOyTJDngEMYBIw8QjzxsJ5OEoMdFnLtd1nU0_nf-H0JeTntBLJ2QrmA4lXXEF_Cfk9-pJ7vYkAU1Ub3gHzX4zK3X22-_gzo0rXD38rBvGh2LyXmmqdSMjQCBk3CMPWs_pZhb7IUCMGngk6flUb-r7I2XxtaFB5xDrp2Hw8O-v9Yjcghh3iNvxEd8lg9VybR5DHLnKnzRg8QuKrnN- priority: 102 providerName: ProQuest |
Title | Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26208220 https://www.proquest.com/docview/1698611493 https://www.proquest.com/docview/1699493134 https://pubmed.ncbi.nlm.nih.gov/PMC4514810 https://doaj.org/article/932220f3050c4df49e3648a297e82a9f http://dx.doi.org/10.1371/journal.pone.0133589 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe2TkK8TGx8LDCKQUiARKp8uEmMhNBWtbRoHdNYp75FjuOUiiopTSuxF_4a_lDuEiciqBO8uFJ8jtLz3fls3_2OkJfd2JbcTwKTKemazEssM2IJKJ7lMl9geaQiw3t87g0n7NO0O90hVc1WzcB869YO60lNVovOj-83H0Dh3xdVG3y7GtRZZqnqgEvjdgO-S_ZgbfJRVcesvlcA7fY8nUB328jGAlXg-NfWurVcZPk2V_TviMo_lqjBPbKvfUt6UgrDAdlR6SG5M9a354fkQCtyTl9rtOk398mvsyydmVdgoGkZH0vnKe1jcQOwNPC2Hua9gBDl85wi3pMospQoPKXV1KqYXs7zb3RQ1u6heLZLs1Xxm23WdDi6piMd9JW-o2dgXEHWKWa2wHtoP40zTI6ZS4pRjTc0S2hgvQUjRy9K1Nf8AZkM-le9oalLN5jS487ahG2QiBNHsQjcUS5jIaQVJFYcgL4LacvAsWUiYuki3BsYgUipiLue4tIRCkTHfUhaKUzKEaFOEoHFjpileMyYsAXmAseR53q-cJ0oNohbzVcoNa45ltdYhMVlnQ_7m5L9Ic5yqGfZIGY9alnievyD_hRFoaZFVO7iQbaahVrJQ47XVlYCJtSSLE4YV67HAvxgFTiCJwZ5hoIUlimutW0JT5gDXgEPbN8gLwoKROZIMfRnJjZ5Ho4-X_8H0ZfLBtErTZRkwA4pdLoF_CdE_GpQHjcowb7IRvcRin3FlTy0PR54sI3mLoysVGF79_O6G1-K4XypyjYFDQcC22UGeVRqTs1ZrJAAXqtlEL-hUw3WN3vS-dcCGJ2B9x_Y1uPbv_gJuQsebxcP5x12TFrr1UY9Ba9yHbXJrj_1oQ16NraDj22yd9o_v7hsF-c07cKQYPuz_xtRy33d |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGkYAXxMbHCoMZBAIksiWxm8RICI3RqWXtmEY39S04jlMqpqQ0rdD-H575G7lLnLCgCXjZU6T4YiW-u5_PuS9CnnZiRwk_CSyuFbO4l9hWxBNQPJtxX2J7pCLDe3jg9Y75h3FnvEJ-VrkwGFZZYWIB1HGm8B_5tuOJwAPjXbC3s28Wdo1C72rVQqMUi3199h2ObPmb_nvg7zPX3euOdnuW6SpgKU-4CwssdBknruYRWEpCxVIqO0jsOABRlMpRgeuoRMaKYSUykM9I60gwTwvlSg1fxWDeK-QqbLw2apQ_rg94gB2eZ9LzmO9sG2nYmmWp3gJTi3Wwmfy57a_oElDvBa3ZaZZfZOj-Ga95bgPcu0VuGsuV7pSitkpWdLpGrg2Nb36NrBqYyOkLU8v65W3yY5ClE2sE8E_L6Fs6TWkXWycAjsFsu5hVAyKaT3OK1aRkkQNF4S6tBEfH9Giaf6V7ZWcgin-OaTYvrtlyQXv9E9o3IWXpazoA6AZNopg3A_PQbhpnmHozVRRjJs9oltDAfgUQSg_LmrL5HXJ8KSy8S1opMGWdUDeJYD-IuK1FzLl0JGYax5HHPF8yN4rbhFX8CpWpmo7NO07DwhXow-mpXP4QuRwaLreJVT81K6uG_IP-HYpCTYs1v4sb2XwSGggJBTrF7AQA2lY8TrjQzOMBvrAOXCmSNtlEQQrLBNoaucId7oLNIQLHb5MnBQXW_UgxsGgil3ke9j-e_AfRp6MG0XNDlGSwHEqaZA74Jqwn1qDcaFACeqnG8DqKfbUqefhbz-HJShUuHn5cD-OkGCyY6mxZ0AggcBhvk3ul5tQri_0XwCa228Rv6FRj6Zsj6fRLUXadw9kicOz7f3-tTXK9NxoOwkH_YP8BuQH2dQddAS7fIK3FfKkfgg27iB4VwEHJ58tGql8Fp7IH |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELbKIlW8IFqOLhRqEAiQSJvE3iRGQqi0XXXpQdVL-xYcxy4rqmTZ7Ar1__Ar-HXMJE5oUAW89ClSPLGSOT6P4zkIed5LPSVCEzlcK-bwwLhOwg0Ynst4KLE9UpnhvbcfbJ_wj8PecI78rHNhMKyyxsQSqNNc4T_yNS8QUQDOu2BrxoZFHGz234-_OdhBCk9a63YalYrs6IvvsH0r3g02QdYvfL-_dbyx7dgOA44KhD91wFuXqfE1T8BrEiqVUrmRcdMI1FIqT0W-p4xMFcOqZKCridaJYIEWypcavpDBvDfIzRAG0cbCYbPZAxwJApuqx0JvzWrG6jjP9Cq4XayHjeUvLYVlx4BmXeiMz_PiKqf3z9jNS4th_w65bb1Yul6p3QKZ09kimd-z5_SLZMFCRkFf2brWr--SH7t5duYcw1JAq0hcOsroFrZRAEyD2TYwwwbUtRgVFCtLyTIfisJdWiuRTunhqPhK-1WXIIp_kWk-Ka_5bEq3B6d0YMPLsrd0F2AcrIpiDg3MQ7eyNMc0nJGiGD95QXNDI_cNwCk9qOrLFvfIybWI8D7pZCCUJUJ9k8DakHBXi5Rz6UnMOk6TgAWhZH6Sdgmr5RUrW0EdG3mcx-WxYAg7qYr9MUo5tlLuEqd5alxVEPkH_QdUhYYW63-XN_LJWWzhJBZ4QOYaAGtX8dRwoVnAI3xhHflSmC5ZQUWKq2TaBsXide6D_yEiL-ySZyUF1gDJ0JrO5Kwo4sGn0_8gOjpsEb20RCYHdihpEzvgm7C2WItyuUUJSKZaw0uo9jVXivi3zcOTtSlcPfy0GcZJMXAw0_mspBFA4DHeJQ8qy2k4i70YwD92uyRs2VSL9e2RbPSlLMHOYZ8Ree7Dv7_WCpkHjIp3B_s7j8gtcLV7eCrg82XSmU5m-jG4s9PkSYkblHy-bqD6BU7rtj0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-Term+Trends+in+Esophageal+Candidiasis+Prevalence+and+Associated+Risk+Factors+with+or+without+HIV+Infection%3A+Lessons+from+an+Endoscopic+Study+of+80%2C219+Patients&rft.jtitle=PloS+one&rft.au=Takahashi%2C+Yuta&rft.au=Nagata%2C+Naoyoshi&rft.au=Shimbo%2C+Takuro&rft.au=Nishijima%2C+Takeshi&rft.date=2015-07-24&rft.pub=Public+Library+of+Science&rft.eissn=1932-6203&rft.volume=10&rft.issue=7&rft_id=info:doi/10.1371%2Fjournal.pone.0133589&rft.externalDocID=1698611493 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |